The processing and storage facilities for IMPs meet the quality and regulatory requirements. We also handle products that require cool and cold storage, as well as narcotics, cytostatic agents and other IMPs that require special handling.

We deliver research medicines to all hospital pharmacies and research centres in Finland in accordance with GDP. Returns of IMPs are collected from research centres and stored pending a disposal permit or export. Upon receiving a written disposal permit, the IMPs are disposed of in accordance with local regulations.

IMPs stored at Tamro can be traced back to the individual package. The electronic system of clinical IMP services enables flexible reporting and also provides the customer with continuous visibility over the location of the IMPs. Tamro has a licence for the industrial manufacture of medicinal products issued by Fimea, which also allows the re-labelling and secondary packaging of IMPs under GMP. The batch release policy for orders is defined in a separate quality agreement.

Please contact our team of experts and we'll take action.

Our service helps to ensure the continuity of the patient's medical care in cases where the availability of the authorised product varies.

• We can find anything from one package of a specific medication for a single patient to replacement products for high-volume pharmaceuticals.
• Many of the products are already in stock, whereas some are ordered when necessary.
• We look for alternative products within our extensive, international supplier network in Europe and the Northern America. We import the special permit product, contact the Pharmaceuticals Pricing Board to apply for reimbursement status and handle the customer communication, if necessary.

According to a 2021 survey conducted on regular and hospital pharmacies, customers are extremely satisfied with the service provided for the special permit products (overall grade 8.8 and NPS 67). Over 70 % of the respondents considered Tamro to be their primary contact in a situation where they need to order medications that require a special permit.

Lauri Itkonen, Pharmacist at the Porvoon Uusi Apteekki pharmacy: "Tamro’s special permit product team are like our right hand in these matters. Tamro has a lot of information about the products that we at the pharmacy do not have or are not even supposed to have. Contacting the customer care team is easy, since they have such an active and solution-oriented attitude. Communicating via email is convenient, and the team usually responds quickly." 

Sami Huilla, in charge of Pfizer’s hospital operations in the Nordic countries: "Although we at Pfizer have invested heavily in production plants and production chain, sometimes we are faced with a global shortage of a certain raw material. During such times, we rely heavily on Tamro’s expertise and networks."

Please contact our team of experts and we'll take action.